Form 8-K - Current report:
SEC Accession No. 0001005286-25-000118
Filing Date
2025-08-18
Accepted
2025-08-18 16:31:55
Documents
13
Period of Report
2025-08-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20250812.htm   iXBRL 8-K 35172
2 EX-16.1 lfcr2025-08x18ex161bdolett.htm EX-16.1 2848
  Complete submission text file 0001005286-25-000118.txt   157182

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20250812.xsd EX-101.SCH 1864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20250812_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20250812_pre.xml EX-101.PRE 12591
15 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20250812_htm.xml XML 2718
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 251228330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)